data_1fes_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fes _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 mtt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.96 118.69 14.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -115.75 -160.97 0.77 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.554 1.542 . . . . 0.0 108.371 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.8 mt -42.66 103.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.355 1.862 . . . . 0.0 109.747 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -76.21 170.54 16.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.53 99.85 6.62 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.4 155.41 21.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.67 130.89 24.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.6 143.52 50.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.561 0.744 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -85.94 98.92 11.08 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 166.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.56 127.18 72.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.02 100.16 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.91 -53.11 10.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.317 1.447 . . . . 0.0 109.443 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.258 14.1 t 41.2 71.56 0.2 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.888 1.675 . . . . 0.0 111.961 -168.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t 65.97 -165.94 0.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.956 0.903 . . . . 0.0 110.238 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m 70.13 -64.1 0.37 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 159.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.41 -57.87 11.02 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.238 0.923 . . . . 0.0 113.228 -165.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 t 37.7 63.92 0.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.221 1.408 . . . . 0.0 111.732 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m 70.57 -24.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.39 148.57 37.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 120.536 1.516 . . . . 0.0 110.596 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.5 -60.64 0.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.9 1.68 . . . . 0.0 111.498 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.93 -42.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.236 1.014 . . . . 0.0 110.982 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -69.62 -53.44 18.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.89 -51.71 38.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.248 0.619 . . . . 0.0 111.39 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 p -61.31 -24.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.707 -0.621 . . . . 0.0 111.706 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.58 -22.71 32.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.753 175.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.8 p -50.92 -40.54 57.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.864 1.666 . . . . 0.0 111.33 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -46.81 -30.39 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.371 1.468 . . . . 0.0 112.853 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 32.55 4.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.368 1.067 . . . . 0.0 111.591 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -38.95 -55.19 2.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 164.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.53 -12.09 19.52 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.201 1.465 . . . . 0.0 114.367 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -2.27 19.29 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.862 1.265 . . . . 0.0 111.553 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.6 t -120.3 138.58 50.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 120.887 -1.133 . . . . 0.0 108.917 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.4 t -85.51 -53.54 5.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -170.5 177.76 3.9 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.783 0.433 . . . . 0.0 110.199 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.83 156.94 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 168.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -140.72 163.98 31.42 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.95 0.795 . . . . 0.0 108.994 159.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mt -141.04 133.11 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.047 0.939 . . . . 0.0 110.207 -170.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -129.22 90.43 3.02 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.333 1.053 . . . . 0.0 109.188 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -43.47 -48.89 7.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.132 1.773 . . . . 0.0 111.886 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -38.33 -55.08 1.39 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.137 1.375 . . . . 0.0 113.283 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -109.47 15.3 23.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.696 0.798 . . . . 0.0 110.458 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 52.43 43.26 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.897 1.279 . . . . 0.0 111.23 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.16 149.94 23.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -133.86 133.19 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -97.2 145.27 26.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.07 113.99 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -103.17 103.85 13.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -164.74 156.55 15.66 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.31 0.644 . . . . 0.0 110.183 -172.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.5 t -85.68 -20.76 28.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.37 0.668 . . . . 0.0 111.146 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.47 146.77 22.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.128 0.571 . . . . 0.0 111.973 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.65 138.72 60.24 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.405 2.07 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -32.35 -56.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.869 2.468 . . . . 0.0 113.322 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -47.67 -46.52 29.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 111.488 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.52 -46.75 86.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.703 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.5 -51.09 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.51 -52.74 27.46 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.679 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.87 -53.77 7.18 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -45.56 93.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.596 0.758 . . . . 0.0 110.178 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.81 -47.48 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -47.47 -50.04 24.06 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.645 1.178 . . . . 0.0 109.267 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.42 -21.98 28.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -73.42 -21.35 60.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 120.162 1.346 . . . . 0.0 112.292 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.36 -4.86 84.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.083 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -77.97 138.66 38.96 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.708 1.754 . . . . 0.0 110.884 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.86 151.39 14.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.47 100.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.924 2.09 . . . . 0.0 107.429 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.7 mtp180 -76.21 -38.39 56.54 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.9 m -168.39 170.6 9.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 126.116 1.767 . . . . 0.0 107.253 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.71 161.65 29.7 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 106.185 -2.766 . . . . 0.0 106.185 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 174.63 11.26 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 126.165 1.786 . . . . 0.0 110.034 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -108.69 151.67 25.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.103 0.961 . . . . 0.0 110.23 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 C--O 1.249 1.052 0 C-N-CA 128.388 2.675 . . . . 0.0 105.492 174.248 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 mtt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.96 118.69 14.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -115.75 -160.97 0.77 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.554 1.542 . . . . 0.0 108.371 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.8 mt -42.66 103.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.355 1.862 . . . . 0.0 109.747 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -76.21 170.54 16.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' CE1' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -122.53 99.85 6.62 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.4 155.41 21.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.67 130.89 24.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.6 143.52 50.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.561 0.744 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -85.94 98.92 11.08 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 166.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.56 127.18 72.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.02 100.16 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.91 -53.11 10.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.317 1.447 . . . . 0.0 109.443 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.258 14.1 t 41.2 71.56 0.2 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.888 1.675 . . . . 0.0 111.961 -168.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t 65.97 -165.94 0.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.956 0.903 . . . . 0.0 110.238 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m 70.13 -64.1 0.37 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 159.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.41 -57.87 11.02 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.238 0.923 . . . . 0.0 113.228 -165.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 t 37.7 63.92 0.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.221 1.408 . . . . 0.0 111.732 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m 70.57 -24.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.39 148.57 37.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 120.536 1.516 . . . . 0.0 110.596 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.5 -60.64 0.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.9 1.68 . . . . 0.0 111.498 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.93 -42.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.236 1.014 . . . . 0.0 110.982 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -69.62 -53.44 18.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.89 -51.71 38.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.248 0.619 . . . . 0.0 111.39 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG13 HD23 ' A' ' 26' ' ' LEU . 3.4 p -61.31 -24.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.707 -0.621 . . . . 0.0 111.706 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 HG13 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -83.58 -22.71 32.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.753 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.8 p -50.92 -40.54 57.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.864 1.666 . . . . 0.0 111.33 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -46.81 -30.39 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.371 1.468 . . . . 0.0 112.853 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 32.55 4.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.368 1.067 . . . . 0.0 111.591 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -38.95 -55.19 2.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 164.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.53 -12.09 19.52 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.201 1.465 . . . . 0.0 114.367 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -2.27 19.29 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.862 1.265 . . . . 0.0 111.553 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.6 t -120.3 138.58 50.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 120.887 -1.133 . . . . 0.0 108.917 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.4 t -85.51 -53.54 5.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -170.5 177.76 3.9 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.783 0.433 . . . . 0.0 110.199 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 36' ' ' ILE . 2.8 mp -127.83 156.94 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -140.72 163.98 31.42 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.95 0.795 . . . . 0.0 108.994 159.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mt -141.04 133.11 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.047 0.939 . . . . 0.0 110.207 -170.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -129.22 90.43 3.02 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.333 1.053 . . . . 0.0 109.188 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -43.47 -48.89 7.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.132 1.773 . . . . 0.0 111.886 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -38.33 -55.08 1.39 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.137 1.375 . . . . 0.0 113.283 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -109.47 15.3 23.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.696 0.798 . . . . 0.0 110.458 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 52.43 43.26 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.897 1.279 . . . . 0.0 111.23 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.16 149.94 23.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -133.86 133.19 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -97.2 145.27 26.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.07 113.99 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -103.17 103.85 13.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -164.74 156.55 15.66 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.31 0.644 . . . . 0.0 110.183 -172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.5 t -85.68 -20.76 28.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.37 0.668 . . . . 0.0 111.146 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.47 146.77 22.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.128 0.571 . . . . 0.0 111.973 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.65 138.72 60.24 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.405 2.07 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -32.35 -56.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.869 2.468 . . . . 0.0 113.322 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -47.67 -46.52 29.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 111.488 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.52 -46.75 86.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.703 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 56' ' ' ILE . 2.0 mp -61.5 -51.09 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.51 -52.74 27.46 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.679 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.87 -53.77 7.18 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -45.56 93.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.596 0.758 . . . . 0.0 110.178 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.81 -47.48 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -47.47 -50.04 24.06 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.645 1.178 . . . . 0.0 109.267 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.42 -21.98 28.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -73.42 -21.35 60.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 120.162 1.346 . . . . 0.0 112.292 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.36 -4.86 84.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.083 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -77.97 138.66 38.96 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.708 1.754 . . . . 0.0 110.884 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.86 151.39 14.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.47 100.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.924 2.09 . . . . 0.0 107.429 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.7 mtp180 -76.21 -38.39 56.54 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.9 m -168.39 170.6 9.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 126.116 1.767 . . . . 0.0 107.253 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.71 161.65 29.7 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 106.185 -2.766 . . . . 0.0 106.185 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 174.63 11.26 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 126.165 1.786 . . . . 0.0 110.034 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -108.69 151.67 25.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.103 0.961 . . . . 0.0 110.23 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 6' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.052 0 C-N-CA 128.388 2.675 . . . . 0.0 105.492 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.8 mtt . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.96 118.69 14.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -115.75 -160.97 0.77 Allowed 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.554 1.542 . . . . 0.0 108.371 -172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.8 mt -42.66 103.55 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.355 1.862 . . . . 0.0 109.747 170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -76.21 170.54 16.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 167.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' CE1' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -122.53 99.85 6.62 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 166.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.4 155.41 21.29 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -140.67 130.89 24.96 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -128.6 143.52 50.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.561 0.744 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -85.94 98.92 11.08 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 166.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.56 127.18 72.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.02 100.16 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.4 tpp -73.91 -53.11 10.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.317 1.447 . . . . 0.0 109.443 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.258 14.1 t 41.2 71.56 0.2 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.888 1.675 . . . . 0.0 111.961 -168.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.0 t 65.97 -165.94 0.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.956 0.903 . . . . 0.0 110.238 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m 70.13 -64.1 0.37 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 159.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.41 -57.87 11.02 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.238 0.923 . . . . 0.0 113.228 -165.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 t 37.7 63.92 0.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.221 1.408 . . . . 0.0 111.732 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.3 m 70.57 -24.01 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.39 148.57 37.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 120.536 1.516 . . . . 0.0 110.596 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 69.5 -60.64 0.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.9 1.68 . . . . 0.0 111.498 -172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.93 -42.71 83.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.236 1.014 . . . . 0.0 110.982 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -69.62 -53.44 18.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -49.89 -51.71 38.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.248 0.619 . . . . 0.0 111.39 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG13 HD23 ' A' ' 26' ' ' LEU . 3.4 p -61.31 -24.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 121.707 -0.621 . . . . 0.0 111.706 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 HG13 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -83.58 -22.71 32.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.753 175.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.8 p -50.92 -40.54 57.37 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.864 1.666 . . . . 0.0 111.33 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.3 tptt -46.81 -30.39 2.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.371 1.468 . . . . 0.0 112.853 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 32.55 4.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.368 1.067 . . . . 0.0 111.591 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -38.95 -55.19 2.93 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 164.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.53 -12.09 19.52 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.201 1.465 . . . . 0.0 114.367 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.36 -2.27 19.29 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.862 1.265 . . . . 0.0 111.553 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.6 t -120.3 138.58 50.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.121 0 O-C-N 120.887 -1.133 . . . . 0.0 108.917 -173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.4 t -85.51 -53.54 5.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -170.5 177.76 3.9 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 122.783 0.433 . . . . 0.0 110.199 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 36' ' ' ILE . 2.8 mp -127.83 156.94 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.153 -2.906 . . . . 0.0 103.153 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -140.72 163.98 31.42 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 118.95 0.795 . . . . 0.0 108.994 159.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.5 mt -141.04 133.11 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.047 0.939 . . . . 0.0 110.207 -170.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.4 m -129.22 90.43 3.02 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.333 1.053 . . . . 0.0 109.188 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -43.47 -48.89 7.34 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.132 1.773 . . . . 0.0 111.886 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -38.33 -55.08 1.39 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.137 1.375 . . . . 0.0 113.283 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -109.47 15.3 23.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.696 0.798 . . . . 0.0 110.458 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 52.43 43.26 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.897 1.279 . . . . 0.0 111.23 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.16 149.94 23.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -133.86 133.19 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -97.2 145.27 26.21 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.0 t -133.07 113.99 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -103.17 103.85 13.95 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -164.74 156.55 15.66 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.31 0.644 . . . . 0.0 110.183 -172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.5 t -85.68 -20.76 28.9 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.37 0.668 . . . . 0.0 111.146 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.4 mt -53.47 146.77 22.58 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.128 0.571 . . . . 0.0 111.973 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.65 138.72 60.24 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.405 2.07 . . . . 0.0 112.031 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -32.35 -56.54 0.33 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.869 2.468 . . . . 0.0 113.322 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -47.67 -46.52 29.22 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 111.488 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.52 -46.75 86.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.703 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 56' ' ' ILE . 2.0 mp -61.5 -51.09 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -49.51 -52.74 27.46 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.679 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -44.87 -53.77 7.18 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -45.56 93.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.596 0.758 . . . . 0.0 110.178 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -59.81 -47.48 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -47.47 -50.04 24.06 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 124.645 1.178 . . . . 0.0 109.267 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -56.42 -21.98 28.72 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -73.42 -21.35 60.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 120.162 1.346 . . . . 0.0 112.292 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.36 -4.86 84.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.886 -0.952 . . . . 0.0 113.083 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -77.97 138.66 38.96 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.708 1.754 . . . . 0.0 110.884 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.86 151.39 14.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.835 0.854 . . . . 0.0 112.488 174.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.47 100.68 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.924 2.09 . . . . 0.0 107.429 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.7 mtp180 -76.21 -38.39 56.54 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.795 0.331 . . . . 0.0 110.918 -172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.9 m -168.39 170.6 9.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 126.116 1.767 . . . . 0.0 107.253 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.71 161.65 29.7 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 106.185 -2.766 . . . . 0.0 106.185 169.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.61 174.63 11.26 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 126.165 1.786 . . . . 0.0 110.034 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -108.69 151.67 25.86 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.103 0.961 . . . . 0.0 110.23 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 6' ' ' HIS . 9.3 mt . . . . . 0 C--O 1.249 1.052 0 C-N-CA 128.388 2.675 . . . . 0.0 105.492 174.248 . . . . . . . . 1 1 . 1 stop_ save_